» Articles » PMID: 35685556

Dietary Inflammatory Potential in Relation to General and Abdominal Obesity

Overview
Publisher Wiley
Specialty General Medicine
Date 2022 Jun 10
PMID 35685556
Authors
Affiliations
Soon will be listed here.
Abstract

/Aims: Limited data are available on the association of Dietary Inflammatory Potential (DIP) with general and abdominal obesity in developing countries. The aim of this study was to examine the association between DIP score with general and abdominal obesity among Iranian adults. . This cross-sectional study was conducted among adults in Isfahan, Iran. Dietary intakes were assessed by using a validated, self-administrated, dish-based, semiquantitative food frequency questionnaire. DIP was calculated based on standard method. Data regarding height, weight, and waist circumference (WC) were collected using a self-reported questionnaire. Overweight or obesity was defined as body mass index (BMI) ≥25 kg/m, and abdominal obesity was defined as WC ≥ 80 cm for women and ≥94 cm for men. . Mean age of study participants was 36.8 ± 8.08 years. The prevalence of general and abdominal obesity was 46.5% and 52.9%, respectively. We observed that higher DIP scores were significantly associated with a lower odds of general obesity (OR: 0.66; 95% CI: 0.58-0.74). Stratified by sex, this significant association was seen only for women (OR: 0.58; 95% CI: 0.46-0.72). In addition, no significant association was found between DIP scores and abdominal obesity. . We found a significant inverse association between consumption of a proinflammatory diet and general obesity. In the gender-stratified analysis, this was seen in women, but not in men. There was no significant association between the DIP scores and abdominal obesity.

References
1.
Salari-Moghaddam A, Keshteli A, Esmaillzadeh A, Adibi P . Adherence to the pro-inflammatory diet in relation to prevalence of irritable bowel syndrome. Nutr J. 2019; 18(1):72. PMC: 6849293. DOI: 10.1186/s12937-019-0487-6. View

2.
Patsalos O, Dalton B, Leppanen J, Ibrahim M, Himmerich H . Impact of TNF-α Inhibitors on Body Weight and BMI: A Systematic Review and Meta-Analysis. Front Pharmacol. 2020; 11:481. PMC: 7174757. DOI: 10.3389/fphar.2020.00481. View

3.
Tabrizi J, Sadeghi-Bazargani H, Farahbakhsh M, Nikniaz L, Nikniaz Z . Prevalence and Associated Factors of Overweight or Obesity and Abdominal Obesity in Iranian Population: A Population-based Study of Northwestern Iran. Iran J Public Health. 2018; 47(10):1583-1592. PMC: 6277719. View

4.
Tzanavari T, Giannogonas P, Karalis K . TNF-alpha and obesity. Curr Dir Autoimmun. 2010; 11:145-56. DOI: 10.1159/000289203. View

5.
Dwivedi A, Dubey P, Cistola D, Reddy S . Association Between Obesity and Cardiovascular Outcomes: Updated Evidence from Meta-analysis Studies. Curr Cardiol Rep. 2020; 22(4):25. DOI: 10.1007/s11886-020-1273-y. View